Signup Crypto ETF Stocks News

Pershing Square to Invest $900 million to Acquire Nine Million Newly Issued Shares of Howard Hughes Holdings and Transform HHH Into a Diversified Holding Company

Pershing Square to Support HHH's Strategic Expansion Through Investment, Advisory, and Other Resources ...

Source: www.globenewswire.com
May 05, 2025 | 11:00:00
Category: News

GXO and Blue Yonder Announce New Strategic Global Agreement

New agreement creates strategic growth opportunities for both companies while delivering industry-leading supply chain solutions for customers ...

Source: www.globenewswire.com
May 05, 2025 | 11:00:00
Category: News

Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ ( ustekinumab-aekn ) with Stelara® ( ustekinumab )

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. ( NYSE and TASE: TEVA ) , and Alvotech ( NASDAQ: ALVO ) today announced that the U.S. Food and Drug Administration ( FDA ) has approved SELARSDI™ ( ustekinumab-aekn ) injection as interchangeable with the reference ...

Source: www.globenewswire.com
May 05, 2025 | 11:00:00
Category: News

Grassy Mountain Gold Project Selected for US Government FAST-41 Program - Paramount Gold Nevada ( AMEX:PZG )

WINNEMUCCA, Nev., May 05, 2025 ( GLOBE NEWSWIRE ) -- Paramount Gold Nevada Corp. PZG ( "Paramount" or the "Company" ) announced today that the high-grade Grassy Mountain gold project in Malheur County, Oregon, has been selected for inclusion in the federal government's FAST-41 program.

Source: www.benzinga.com
May 05, 2025 | 11:00:00
Category: General

Grassy Mountain Gold Project Selected for US Government FAST-41 Program

Paramount Gold's Grassy Mountain gold project has been included in the federal governments FAST-41 list.

Source: www.globenewswire.com
May 05, 2025 | 11:00:00
Category: News

Dianthus Therapeutics Completes Enrollment of Phase 2 MaGic Trial of DNTH103 in Generalized Myasthenia Gravis With Top-Line Results Expected in September

MaGic trial exceeded enrollment target of 60 patients ...

Source: www.globenewswire.com
May 05, 2025 | 11:00:00
Category: News

Update to Zijin Put Option and Exclusivity Arrangements

TORONTO, May 05, 2025 ( GLOBE NEWSWIRE ) -- Xanadu Mines Ltd ( ASX: XAM, TSX: XAM ) ( Xanadu or the Company ) refers to its announcement dated 7 April 2025 in relation to the Extension of the Zijin Put Option and Exclusivity Arrangements1 with its major shareholder and Joint Venture Partner, ...

Source: www.globenewswire.com
May 05, 2025 | 11:00:00
Category: News

ANI Pharmaceuticals Announces Presentation of Preclinical Data on the Use of Purified Cortrophin® Gel in an Experimental Autoimmune Uveitis ( EAU ) Mouse Model - ANI Pharmaceuticals ( NASDAQ:ANIP )

Demonstrated Dose Dependent Effect in EAU Presented in a podium presentation at The Association for Research in Vision and Ophthalmology ( ARVO ) 2025 annual meeting

Source: www.benzinga.com
May 05, 2025 | 11:00:00
Category: General

PLBY Group to Report First Quarter 2025 Financial Results on May 15, 2025 - PLBY Group ( NASDAQ:PLBY )

LOS ANGELES, May 05, 2025 ( GLOBE NEWSWIRE ) -- PLBY Group, Inc. PLBY ( "PLBY Group" or the "Company" ) , a leading pleasure and leisure lifestyle company and owner of Playboy, one of the most recognizable and iconic brands in the world, will report first quarter 2025 financial results on ...

Source: www.benzinga.com
May 05, 2025 | 11:00:00
Category: News

Aquestive Therapeutics to Participate in Citizens Life Sciences Conference - Aquestive Therapeutics ( NASDAQ:AQST )

WARREN, N.J., May 05, 2025 ( GLOBE NEWSWIRE ) -- Aquestive Therapeutics, Inc.

Source: www.benzinga.com
May 05, 2025 | 11:00:00
Category: News

© Natavest 2025 - 2026